Home Federal (HFBL) files Form 144 for 8,200-share sale via Raymond James
Rhea-AI Filing Summary
Form 144 filed for Home Federal Bancorp, Inc. (HFBL) reporting a proposed sale of 8,200 shares of common stock through Raymond James with an aggregate market value of $110,700. The filing lists total outstanding shares as 3,084,764 and an approximate sale date of 09/17/2025. The shares to be sold were acquired in a series of stock awards between 2016 and 2024, most recently 3,000 shares awarded on 05/31/2024. The filer states no securities were sold in the past three months and includes the required attestation about material nonpublic information.
Positive
- None.
Negative
- Proposed sale of 8,200 shares of common stock, aggregate market value $110,700, on or about 09/17/2025
Insights
TL;DR An insider sale of 8,200 shares (about $110.7k) is reported; size appears modest relative to total outstanding shares.
The filing documents a planned disposition of 8,200 common shares via Raymond James with an indicated aggregate market value of $110,700 and an approximate sale date of 09/17/2025. Acquisition history shows these shares stem from recurring stock awards granted from 2016 through 2024, including a 3,000-share award on 05/31/2024. No sales in the prior three months are reported. From a financial perspective, the disclosed amount represents approximately 0.27% of the stated 3,084,764 shares outstanding, indicating the transaction is modest in scale on a share-count basis. The filing contains standard representations required by Rule 144.
TL;DR The Form 144 is a routine insider notice showing a planned sale of previously awarded shares; disclosure and attestations are included.
The document provides required details: broker name and address, number of shares to be sold, aggregate market value, acquisition dates and nature of acquisition (stock awards), and an attestation that the seller lacks undisclosed material information. The schedule of award dates from 2016 to 2024 documents the provenance of the shares. The filing does not disclose any trading plan adoption date or additional instructions under Rule 10b5-1, and no sales in the past three months are recorded. Governance-wise, the submission meets Rule 144 disclosure elements without indicating any compliance exceptions.